Host response transcriptional profiling reveals extracellular components and ABC (ATP-binding cassette) transporters gene enrichment in typhoid fever-infected Nigerian children
© Khoo et al; licensee BioMed Central Ltd. 2011
Received: 4 May 2011
Accepted: 13 September 2011
Published: 13 September 2011
Salmonella enterica serovar Typhi (S. Typhi) is a human-specific pathogen that causes typhoid fever, and remains a global health problem especially in developing countries. Its pathogenesis is complex and host response is poorly understood. In Africa, typhoid fever can be a major cause of morbidity in young infected children. The onset of the illness is insidious and clinical diagnosis is often unreliable. Gold standard blood culture diagnostic services are limited, thus rapid, sensitive, and affordable diagnostic test is essential in poor-resourced clinical settings. Routine typhoid fever vaccination is highly recommended but currently licensed vaccines provide only 55-75% protection. Recent epidemiological studies also show the rapid emergence of multi-drug resistant S. Typhi strains. High-throughput molecular technologies, such as microarrays, can dissect the molecular mechanisms of host responses which are S. Typhi-specific to provide a comprehensive genomic component of immunological responses and suggest new insights for diagnosis and treatment.
Global transcriptional profiles of S. Typhi-infected young Nigerian children were obtained from their peripheral blood and compared with that of other bacteremic infections using Agilent gene expression microarrays. The host-response profiles of the same patients in acute vs. convalescent phases were also determined. The top 96-100 differentially-expressed genes were identified and four genes were validated by quantitative real-time PCR. Gene clusters were obtained and functional pathways were predicted by DAVID (Database for Annotation, Visualization and Integrated Discovery).
Transcriptional profiles from S. Typhi-infected children could be distinguished from those of other bacteremic infections. Enriched gene clusters included genes associated with extracellular peptides/components such as lipocalin (LCN2) and systemic immune response which is atypical in bacterial invasion. Distinct gene expression profiles can also be obtained from acute vs. convalescent phase during typhoid fever infection. We found novel down-regulation of ABC (ATP-binding cassette) transporters genes such as ABCA7, ABCC5, and ABCD4 and ATPase activity as the highest enriched pathway.
We identified unique extracellular components and ABC transporters gene enrichments in typhoid fever-infected Nigerian children, which have never been reported. These enriched gene clusters may represent novel targeted pathways to improve diagnostic, prognostic, therapeutic and next-generation vaccine strategies for typhoid fever in Africa.
Salmonella enterica serovar Typhi (S. Typhi) is a Gram-negative bacterium that causes typhoid fever. The World Health Organization (WHO) recognizes S. Typhi infection as a global health problem, with an estimated 21 million cases and between 200,000 and 600,000 deaths annually [1, 2]. In Africa, typhoid fever affects mainly school-age children and younger adults . In fact, in endemic and large outbreak areas, young children represent a subgroup with the highest burden of infection as well as high rates of morbidity and complications . The clinical diagnosis is often unreliable and confused with other febrile illness. Definitive diagnosis through blood or bone-marrow culture is laborious, expensive, and/or invasive, with sensitivity of only 40 to 70% [2, 5]. Moreover, it takes several days for isolation and identification that can cause a delay to initiate proper antibiotic treatment. On the other hand, serologic diagnostic tests such as Widal tests lack sensitivity and specificity [6, 7]. Lack of precision in diagnosis often implies non-targeted use of broad spectrum antibiotics which leads to the rise of multi-drug resistant strains . A primary preventive strategy for disease prevention is vaccination. However, protective efficacies of both internationally licensed vaccines, Vi and Ty21, are modest (< 75%) [9, 10]. As long as the understanding of pathogenesis of typhoid fever remains incomplete, improvement on diagnosis, treatment and vaccine strategies will be subsequently delayed.
One of the approaches to elucidate the pathogenesis of typhoid fever is to better understand the mechanisms of virulence and susceptibility of hosts. Host responses to bacterial infections are determined by specific structural and antigenic components of the bacteria and the profile of immunological response should be unique to different classes of bacteria or bacteria species. Global transcriptional profiling of the peripheral blood using microarrays has been proven feasible to identify distinct host responses in various diseases [11–16]. In the field of infectious diseases, a host's immune response to a certain pathogen can be clearly defined and its unique molecular signature identified using high-throughput microarray technology, eliminating the limitation of conventional diagnostic or microbiological techniques.
This is the first host response transcriptional profiling study on young children with typhoid fever in Africa. Our preliminary observations showed distinct transcriptional profiles between S. Typhi vs. other bacteremic-infected children, as well as acute vs. convalescent phase. We identified novel sets of genes associated with extracellular components which are specific to S. Typhi infection, as well as the ABC transporters gene cluster which can discriminate acute from convalescence phases.
This is a sub study for our CABSYNC (Community- Acquired Bacteremic Syndrome in Young Nigerian Children) surveillance program for children aged 2 months to 14 years in central Nigeria. Children with fever (temperature ≥ 38.5°C) and any of the following: respiratory distress, convulsion or diarrhea, were eligible for enrollment. Since the use of antibiotics could modify the transcriptional profile, only treatment-naïve patients were recruited. Blood was drawn using aseptic technique for culture into an aerobic Pediatric plus Bactec culture bottle (Becton Dickinson (BD)) which contains antibiotic resins. The bottles were incubated for no longer than 5 days in the Bactec 9050 instrumented blood culture systems (BD). Positive specimens were Gram stained and sub-cultured on appropriate agar plates. After primary isolation and characterization, secondary confirmation was performed at the Medical Research Council Laboratories, Gambia, or Sparrow Regional Laboratories, East Lansing, Michigan, USA. Salmonella isolates were further characterized at the Sanger Institute, Oxford, United Kingdom. Antibiotic susceptibility testing was performed using standard methods. Antimicrobial activity in serum was detected using the Micrococcus luteus assay. Blood from acute (before initiating antibiotics) and convalescent (4 weeks after acute presentation) phases of the same patients were sampled. Parental consents were obtained from all children in this study. This study was approved by the Institutional Review Board of Michigan State University and the National Hospital, and the Ethics committee of the Federal Capital Territory Abuja, Nigeria.
RNA extraction and purification
Two to five milliliters of peripheral blood were drawn from each subject into a PAXgene blood RNA tube (BD). PAXgene tubes contain a proprietary reagent that immediately stabilizes intracellular RNA for 3 days at 18-25°C and 5 days at 2-8°C, and thereafter at -70°C for long-term storage. The PAXgene blood RNA system is a product approved by the US FDA for collection, storage, and transport of blood for molecular diagnostic testing. Extraction and purification protocols were performed according to PAXgene blood RNA kit (Qiagen). The quality and quantity of RNA was measured on a RNA nano microfluidic chip using the BioAnalyzer (Agilent Technologies).
Whole human genome 4 × 44K gene expression 2-color microarrays from Agilent were used in this study. In brief, 200 ng of total RNA was amplified, fluorescently labeled, and hybridized onto the arrays according to the manufacturer's protocols. RNA from acute phase was labeled with Cy3 (green dye) and convalescence phase with Cy5 (red dye). After hybridization, the arrays were washed and scanned with an Agilent scanner. Probe features were extracted from the microarray scan data using Feature Extraction software v.184.108.40.206 (Agilent). Microarray data were deposited in Gene Expression Omnibus (GEO) with the accession number #GSE28658.
Gene expression analysis
The gene expression of each sample was loaded into the R environment and the Limma package was applied for analysis. Data were background corrected in order to obtain accurate intensity values while red and green channels were separated and quantile normalization was applied to remove systemic/technical variations before statistical analysis. A linear model was applied before eBayes test and top up- or down-regulated genes were generated. The statistic used for significance analysis was the moderated t-test. This has the same interpretation as a standard t-test except that the standard errors were moderated across genes, i.e., shrunk towards a common value, using a simple Bayesian model. As the number of samples is small, we chose to use the moderated t-test in this pilot study as an exploratory approach to identify differentially- expressed genes.
The Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources v.6.7 from the National Institute of Allergy and Infectious Diseases (NIAID/NIH) http://david.abcc.ncifcrf.gov/, a gene-centered database integrating heterogeneous gene annotation resources, was applied to facilitate high-throughput gene functional/pathway analysis [17, 18]. The group enrichment score, the geometric mean (in -log scale) of member's P-values in a corresponding annotation cluster, is used to rank their functional significance.
Quantitative Real time PCR (Q-PCR)
Specific TaqMan gene expression assays for Q-PCR and amplicon lengths
TaqMan assay ID
Amplicon length (bp)
Results and discussion
Clinical data of patients and feasibility of recruitment
Clinical data of Nigerian children with S. Typhi and other bacteremic infections
6 yrs 4 mo
fever 14 days, diarrhea 4 days
3 yrs 4 mo
fever 14 days, cough with difficult breathing 1 day
fever 5 days
6 yrs 4 mo
fever, vomiting, diarrhea 5 days, cough 7 days
5 yrs 1 mo
fever 30 days, diarrhea 14 days
12 yrs 1 mo
fever 30 days, diarrhea 14 days
Previously, we showed that typhoid fever is the most prominent infectious disease among Nigerian children from our CABSYNC (Community- Acquired Bacteremic Syndrome in Young Nigerian Children) surveillance data between September 2008 and November 2009, screening 1,287 children aged 2 months to 5 years . Therefore, it is critical to elucidate the molecular mechanisms of host response in African children with typhoid fever, an under-represented yet extremely important research cohort. Transcriptional microarray studies require intracellular RNA which can be a challenge since RNA can be unstable and rapidly degrade within hours after blood collection. In this pilot study, we showed that it is feasible to collect whole blood samples from African children using PAXgene Blood RNA tubes which contain an additive that stabilizes the in vivo gene transcription profile by reducing in vitro RNA degradation and minimizing gene induction. Moreover, PAXgene tubes can be safely stored or transported at 15-25°C for up to 3 days or at 2-8°C for up to 5 days, thus suitable for blood collection in freezer-lacking rural areas in Africa.
Transcriptional profiles of S. typhi patients
S. Typhi infection-specific genes and pathways
The top 96 differentially-expressed genes (P < 0.05, fold change > 2.5) between S. Typhi-infected children and other bacteremia (Figure 1)(Additional file 1) included genes that are involved in ligand binding and alteration of cell composition such as lipocalin (LCN2) and prosaposin (PSAP). LCN2 was down-regulated, which is an atypical response for bacterial invasion. In addition, genes associated with systemic inflammatory response such as interleukin 4 (IL4) and tumor necrosis factor (ligand) superfamily, member 9 (TNFSF9) were found up-regulated, which is another example of an atypical bacterial invasion response. We used DAVID to assign annotation groups based on gene ontologies and, as expected, top ranked clusters included genes related to extracellular proteins and components as well as systemic defense and inflammatory response pathways (Additional file 2).
In the human host, detection of pathogens is achieved through pattern-recognition receptors (PPRs) such as the membrane-localized Toll-like receptors (TLRs)  and the cytosolic nucleotide-binding and oligomerization domain-like receptors  of the host innate immune-surveillance system. PRRs function as bar-code readers that recognize conserved molecular structures in microbes known as microbe-associated molecular patterns . With a focus on the extracellular protein and component gene clusters (highest enrichment score in our study), we found down-regulation (-3.6 fold) of LCN2 (lipocalin-2 or neutrophil gelatinase-associated lipocalin) in typhoid fever children intriguing. Lipocalins are extracellular proteins that display different molecular recognition properties such as ligand and receptor binding. Hence, they are known to bind with small hydrophobic molecules, cell surface receptors, as well as form complexes with other macromolecules. The invariant end of the lipocalin fold may implicate the general binding to common cell surface receptors, while the more variable end is adapted to specialized ligand binding and forming of macromolecular complexes . During bacterial invasion, TLRs in immune cells stimulates transcription, translation, and secretion of lipocalin 2 protein (Lcn2) to sequester the siderophore enterobactin (Ent) and inhibit intracellular microbial growth by blocking iron intake . Lcn2 may also represent a novel mechanism of sensing microbial metabolism to modulate the host response . Lcn2 can be up-regulated by pro-inflammatory cytokines such as IL-17, IL-22, and IL-1α to provide a robust innate response in a typical microbial infection [27–30]. However, we found LCN2 down-regulated in typhoid fever children, an observation of an atypical antibacterial response. One explanation is that having the iroA gene cluster in some bacteria such as Salmonella spp allows bacteria to evade this effector mechanism of the innate immune system, rejuvenating their Ent-mediated iron-acquisition pathway and play a role in their virulence . One can also debate the potential of the hydrophobic adhesion protein of S Typhi such as T2544  which binds directly to Lcn2 or TLRs which bind to Lcn2 and causes transcriptional disruption and down-regulation of LCN2. If so, such hydrophobic adhesion proteins can be a potential immune-modulatory target for typhoid fever. In general, our findings on differentially-expressed genes in typhoid fever children can lead us to explore the genes related with extracellular proteins and/or atypical bacterial inflammatory response for future development of typhoid fever-specific diagnostic tools/biomarker panels and anti-typhoid fever strategies and therapies.
It has been suggested that host responses are often typical for groups of pathogens instead of being specific to individual pathogens, as some pathogens share basic clinical characteristics such as fever and diarrhea . However, S. Typhi is known to be an atypical bacterium which does not elicit a typical antibacterial host response characterized by exudative intestinal inflammation, but a nonspecific response of interstitial inflammation resembling viral or parasitic infections . Here, we showed up-regulation of IL4 and TNFSF9 in S. Typhi patients. An increased IL4 level is known to be associated with immune system response in chronic viral hepatitis  while TNFSF9 is reported over-expressed in primary biliary cirrhosis, an autoimmune disease of medium and small bile ducts . Both are cytokines associated with T-cells which have protective capability for systemic inflammation. We also showed down-regulation of HRP (haptoglobin-related protein) and HP (haptoglobin), indicating a systemic response. HPR is commonly regulated as the innate host immunity against Trypanosoma, a protozoan parasite [36, 37]. Our results reinforced the opinion that S. Typhi does not elicit classic antibacterial host responses.
Expressed genes and pathways during acute and convalescence phases
The distinct transcriptional profile of the acute phase consisted of genes related with hemoglobin (hemogloblin-beta, HBB; hemoglobin subunit alpha 1 and 2, HBA 1 and HBA2) and inflammatory (interleukin 11 receptor, alpha, IL11RA; mucin 20, cell surface associated, MUC20) that were down-regulated but up-regulated in the convalescence phase (Figure 2)(Additional file 3). Interestingly, down-regulation of ABC transporter genes (ATP-binding cassette, subfamily A, member 7, ABCA7; ATP-binding cassette, subfamily C, member 5, ABCC5; ATP-binding cassette, subfamily D, member 4, ABCD4) and enrichment of this pathway in the acute phase of typhoid fever patients were detected and the ATPase activity molecular function was clustered as a top-scoring biological function (Additional file 4).
Genes associated with the distinct transcript profiles at different phases of illness have been identified in a cohort of Vietnamese typhoid fever patients (age unknown) . Here, we presented transcriptional profiles and differentially-expressed genes of acute and convalescent phases in a small, unique cohort (young children with African descent) which represents the most prominent typhoid fever-infected yet under-represented group in Nigeria. Genes related to hemoglobin such as HBB, HBA 1 and HBA2 were down-regulated, reflecting the anemic characteristic of typhoid fever patients and are consistent with those reported in the Vietnamese cohort . However, we found down-regulation of inflammatory-related genes such as IL11RA and MUC20 at the initial acute phase but up-regulated 4 weeks later in the convalescent phase. These results are different from the Vietnamese cohort where most immune response genes were over-expressed in acute phase and down-regulated later in convalescent phase. While we are uncertain whether the Vietnamese cohort was sampled before or after initiation of antibiotics (besides unknown age), our study involved young children (average age = 5 years 7 months) that were sampled before antibiotics prescription in their acute phase and 2 patients (09 and 11) have prolonged fever of 30 days. Thus, we can surmise that the innate response of our patients may not have been fully effective during the initial acute phase and took a longer time to recover (hence still maintaining up-regulation of immunological-related genes after 4 weeks) due to their young age and not fully developed/weaker immunity. In addition, it has been reported that a switch from pro-inflammatory to an anti-inflammatory mode occurred and inhibited production of cytokines in the acute phase of typhoid fever patients . It can also be explained by the 'stealth' tactics of S. Typhi, evading recognition of TLR4 and TLR5, impairing identification of its invasion to prevent a typical antibacterial host response, which results in suppression of neutrophil recruitment  and weak induction of acute phase responses .
From our unique cohort, we also identified down-regulation of ABC transporter genes (ATP-binding cassette, subfamily A, member 7, ABCA7; ATP-binding cassette, subfamily C, member 5, ABCC5; ATP-binding cassette, subfamily D, member 4, ABCD4) and enrichment of this pathway in the acute phase of typhoid fever, which have never been previously reported. ABC proteins transport a wide variety of substrates ranging from small ions to macromolecules across the cell membrane. Its export systems in all living organisms are involved in the extrusion of harmful substances and export of extracellular toxins, which can be S. Typhi bacterium in our case, but needs further validation. The same explanation can be given that the ABC transporter genes were down-regulated in the initial acute phase but up-regulated 4 weeks later due to a slower and less efficient host response caused by young age and weaker immunity.
Human ATP-binding cassette transporter superfamily is also known to be involved in drug response phenotypes. Antimicrobial drug resistance of S. Typhi is well known  and our findings may shed light to the appropriate antibiotic treatment to prevent the development of resistant strains of S. Typhi which is an emerging problem. While the definite functions of ABCA7 and ABCD4 are unknown, ABCC5 is a member of the MRP (multi-resistance protein) subfamily and may contribute to resistance of certain anti-cancer and anti-HIV drugs [42–44]. Thus, whether ABCC5 plays a direct or indirect role in multi-drug resistance to typhoid fever antibiotics warrants further investigation.
Transcriptional profiles from the recovery phase were not available as these samples were not acquired during this pilot study. One would predict that most recovery profiles would fail to show distinctive signatures of acute and convalescent stages. However, patients who retain the convalescent signature in the recovery phase may be an indication of carrier state, relapse or susceptible to reinfection . We are currently planning to include the recovery phase, beside acute and convalescent phases, in a follow-up study with a larger cohort (> 100 African children).
Validation of microarray gene expression with Q-PCR
Validation of gene expression using Q-PCR
Average fold change using 2-ΔΔCT method
S . Typhi infection
Other bacteremic infection
S . Typhi acute phase
S . Typhi convalescent phase
It is well known that current diagnostic tests for typhoid fever are inadequate in many ways and development of reliable and affordable diagnostic assays is critical to fill this gap for better disease control and treatment . In this pilot study, we explored the global transcriptomes of Nigerian children with typhoid fever. This led to the characterization of distinct transcriptional profiles for children specifically with typhoid fever and during acute vs. convalescent phases. We showed that evaluating naïve patients (before any antibiotic treatment) may obtain more accurate molecular signatures for diagnostic and progression of typhoid fever. This unique cohort (treatment-naïve, average age of 5 years 7 months) is also more suitable for strategizing novel vaccines as young children are the preferred age for immunization to induce effective and long-lasting immunity. We confirmed that S. Typhi elicits atypical antibacterial host response. We also identified novel extracellular component and ABC transporters as key gene clusters in these young patients which may lead to a more complete understanding of typhoid fever. These enriched gene clusters may represent novel targeted pathways to improve diagnostic, prognostic, therapeutic and next-generation vaccine strategies of typhoid fever in Africa.
Acknowledgements and Funding
We thanked all children who participated and their parents who gave their consent for this study. This study is partially funded by the Van Andel Foundation.
- Bhutta ZA, Threlfall J: Addressing the global disease burden of typhoid fever. JAMA. 2009, 302 (8): 898-899. 10.1001/jama.2009.1259.View ArticlePubMedGoogle Scholar
- WHO: Background document: the diagnosis, prevention and treatment of typhoid fever. WHO. 2003, 19-23.Google Scholar
- Feasey NA, Archer BN, Heyderman RS, Sooka A, Dennis B, Gordon MA, Keddy KH: Emerg Infect Dis. 16 (9): 1448-1451.
- Bhutta ZA: Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child. 1996, 75 (3): 214-217. 10.1136/adc.75.3.214.View ArticlePubMedPubMed CentralGoogle Scholar
- Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ: Typhoid fever. N Engl J Med. 2002, 347 (22): 1770-1782. 10.1056/NEJMra020201.View ArticlePubMedGoogle Scholar
- Dutta S, Sur D, Manna B, Sen B, Deb AK, Deen JL, Wain J, Von Seidlein L, Ochiai L, Clemens JD, et al: Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India. Diagn Microbiol Infect Dis. 2006, 56 (4): 359-365. 10.1016/j.diagmicrobio.2006.06.024.View ArticlePubMedGoogle Scholar
- Mweu E, English M: Typhoid fever in children in Africa. Trop Med Int Health. 2008, 13 (4): 532-540. 10.1111/j.1365-3156.2008.02031.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Cooke FJ, Wain J: The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis. 2004, 2 (2): 67-74. 10.1016/j.tmaid.2004.04.005.View ArticlePubMedGoogle Scholar
- Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN: Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine. 1996, 14 (5): 435-438. 10.1016/0264-410X(95)00186-5.View ArticlePubMedGoogle Scholar
- Whitaker JA, Franco-Paredes C, del Rio C, Edupuganti S: Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med. 2009, 16 (1): 46-52. 10.1111/j.1708-8305.2008.00273.x.View ArticlePubMedGoogle Scholar
- Loke P, Hammond SN, Leung JM, Kim CC, Batra S, Rocha C, Balmaseda A, Harris E: Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis. 4 (6): e710-
- Ardura MI, Banchereau R, Mejias A, Di Pucchio T, Glaser C, Allantaz F, Pascual V, Banchereau J, Chaussabel D, Ramilo O: Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One. 2009, 4 (5): e5446-10.1371/journal.pone.0005446.View ArticlePubMedPubMed CentralGoogle Scholar
- Andersson H, Hartmanova B, Back E, Eliasson H, Landfors M, Naslund L, Ryden P, Sjostedt A: Transcriptional profiling of the peripheral blood response during tularemia. Genes Immun. 2006, 7 (6): 503-513. 10.1038/sj.gene.6364321.View ArticlePubMedGoogle Scholar
- Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, et al: Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun. 2005, 73 (6): 3714-3724. 10.1128/IAI.73.6.3714-3724.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, et al: Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis. 2005, 191 (10): 1599-1611. 10.1086/429297.View ArticlePubMedGoogle Scholar
- Wittwer M, Grandgirard D, Rohrbach J, Leib SL: Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis. BMC Infect Dis. 10: 176-
- Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009, 4 (1): 44-57.View ArticlePubMedGoogle Scholar
- Huang da W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37 (1): 1-13. 10.1093/nar/gkn923.View ArticlePubMedGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
- Obaro S, Lawson L, Essen U, Ibrahim K, Brooks K, Otuneye A, Shetima D, Ahmed P, Ajose T, Olugbile M, et al: Community acquired bacteremia in young children from central Nigeria- a pilot study. BMC infectious diseases. 2011, 11: 137-10.1186/1471-2334-11-137.View ArticlePubMedPubMed CentralGoogle Scholar
- Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5 (10): 987-995. 10.1038/ni1112.View ArticlePubMedGoogle Scholar
- Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG, Nunez G: Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol. 2008, 10 (1): 1-8.PubMedGoogle Scholar
- Hoebe K, Janssen E, Beutler B: The interface between innate and adaptive immunity. Nat Immunol. 2004, 5 (10): 971-974. 10.1038/ni1004-971.View ArticlePubMedGoogle Scholar
- Flower DR: Multiple molecular recognition properties of the lipocalin protein family. J Mol Recognit. 1995, 8 (3): 185-195. 10.1002/jmr.300080304.View ArticlePubMedGoogle Scholar
- Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004, 432 (7019): 917-921. 10.1038/nature03104.View ArticlePubMedGoogle Scholar
- Bachman MA, Miller VL, Weiser JN: Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog. 2009, 5 (10): e1000622-10.1371/journal.ppat.1000622.View ArticlePubMedPubMed CentralGoogle Scholar
- Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, et al: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med. 2008, 14 (3): 275-281. 10.1038/nm1710.View ArticlePubMedPubMed CentralGoogle Scholar
- Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF, Hosoi K, Nagata T, Kido JI: Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1alpha. Arch Oral Biol.
- Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009, 206 (2): 299-311. 10.1084/jem.20081463.View ArticlePubMedPubMed CentralGoogle Scholar
- Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA, Butler BP, Chu H, Santos RL, Berger T, et al: Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe. 2009, 5 (5): 476-486. 10.1016/j.chom.2009.03.011.View ArticlePubMedPubMed CentralGoogle Scholar
- Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, et al: The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA. 2006, 103 (44): 16502-16507. 10.1073/pnas.0604636103.View ArticlePubMedPubMed CentralGoogle Scholar
- Ghosh S, Chakraborty K, Nagaraja T, Basak S, Koley H, Dutta S, Mitra U, Das S: An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development. Proc Natl Acad Sci USA. 108 (8): 3348-3353.
- Tsolis RM, Young GM, Solnick JV, Baumler AJ: From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol. 2008, 6 (12): 883-892. 10.1038/nrmicro2012.View ArticlePubMedGoogle Scholar
- Goncharova IA, Beloborodova EV, Freidin MB, Beloborodova EI, pyzurev VP: [Association of immune system gene polymorphisms with quantitative features which are pathogenetically important in chronic viral hepatitis]. Mol Biol (Mosk). 2008, 42 (2): 242-246.Google Scholar
- Xia R, Tang Y, Huang Y, Yao D, Zhou Y, Chen B, Chen Y, Chen S, Deng A, Zhong R: TNFSF9 expression in primary biliary cirrhosis and its clinical significance. Cytokine. 50 (3): 311-316.
- Vanhollebeke B, De Muylder G, Nielsen MJ, Pays A, Tebabi P, Dieu M, Raes M, Moestrup SK, Pays E: A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science. 2008, 320 (5876): 677-681. 10.1126/science.1156296.View ArticlePubMedGoogle Scholar
- Thomson R, Samanovic M, Raper J: Activity of trypanosome lytic factor: a novel component of innate immunity. Future Microbiol. 2009, 4 (7): 789-796. 10.2217/fmb.09.57.View ArticlePubMedPubMed CentralGoogle Scholar
- Thompson LJ, Dunstan SJ, Dolecek C, Perkins T, House D, Dougan G, Nguyen TH, Tran TP, Doan CD, Le TP, et al: Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci USA. 2009, 106 (52): 22433-22438. 10.1073/pnas.0912386106.View ArticlePubMedPubMed CentralGoogle Scholar
- Keuter M, Dharmana E, Gasem MH, van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WM, Demacker P, Sauerwein R, Gallati H, van der Meer JW: Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis. 1994, 169 (6): 1306-1311. 10.1093/infdis/169.6.1306.View ArticlePubMedGoogle Scholar
- Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, Lawhon SD, Chu H, Lau T, Bevins CL, et al: The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun. 2007, 75 (9): 4342-4350. 10.1128/IAI.01571-06.View ArticlePubMedPubMed CentralGoogle Scholar
- Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Baumler AJ: The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol. 2008, 10 (4): 876-890. 10.1111/j.1462-5822.2007.01090.x.View ArticlePubMedGoogle Scholar
- Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, et al: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA. 2000, 97 (13): 7476-7481. 10.1073/pnas.120159197.View ArticlePubMedPubMed CentralGoogle Scholar
- Oguri T, Isobe T, Suzuki T, Nishio K, Fujiwara Y, Katoh O, Yamakido M: Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int J Cancer. 2000, 86 (1): 95-100. 10.1002/(SICI)1097-0215(20000401)86:1<95::AID-IJC15>3.0.CO;2-G.View ArticlePubMedGoogle Scholar
- Ravna AW, Sager G: Molecular modeling studies of ABC transporters involved in multidrug resistance. Mini Rev Med Chem. 2009, 9 (2): 186-193. 10.2174/138955709787316065.View ArticlePubMedGoogle Scholar
- Baker S, Favorov M, Dougan G: Searching for the elusive typhoid diagnostic. BMC Infect Dis. 10: 45-
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/11/241/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.